Jh. Deleon et al., SLOW ACETYLATION IN MICE IS CAUSED BY A LABILE AND CATALYTICALLY IMPAIRED MUTANT N-ACETYLTRANSFERASE (NAT2-9), Drug metabolism and disposition, 23(12), 1995, pp. 1354-1361
Three N-acetyltransferase genes (NAT) were detected in inbred parenta
l and congenic mice, Direct sequencing of NAT2 and liver cytosolic N-
acetylation activity determinations with NAT2-specific (p-aminobenzoic
acid) and NAT2-selective (2-aminofluorene) substrates have establishe
d that the acetylator congenic A.B6 and B6.A mice are genotypically an
d phenotypically identical to the parental B6 (''wild-type''; rapid ac
etylator) and A (mutant; slow acetylator) mice, respectively, from whi
ch they originated, The apparent K-M for p-aminobenzoic acid and therm
al inactivation rates determined with liver cytosol from the mutant (A
and B6.A) mice were 3-fold and one order of magnitude higher than the
corresponding values with liver cytosol from the wild-type (B6 and A,
B6) strains, Northern blotting and immunoblotting revealed hepatic NAT
2 mRNA and protein bands of equal size and intensity, regardless of th
e NAT2 genotype or phenotype of the animals. Incubation of liver cyto
sol from mutant A and B6.A mice at 37 degrees C for 6 hr resulted in v
irtual cessation of p-aminobenzoate N-acetylation activity, whereas th
e steady-state level of immunoreactive NAT2 remained unchanged, The re
sults indicate that the amino acid change (N991) in mutant NAT2 from
slow acetylator mice does not hinder the synthesis of hepatic NAT2 pro
tein, but, rather, leads to production of a conformationally modified
NAT2 molecule that resists degradation by tissue proteases but is labi
le and catalytically impaired.